+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Antimicrobial Susceptibility Testing Market Size, Share & Industry Trends Analysis Report by Application, Method, Type, End User, Product, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 110 Pages
  • March 2023
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5779085
The North America Antimicrobial Susceptibility Testing Market should witness market growth of 5.4% CAGR during the forecast period (2022-2028).

The overuse and misuse of antibiotics leading to antimicrobial resistance (AMR) and the rising utilization of antimicrobial susceptibility testing by biotechnological, biopharmaceutical, and pharmaceutical companies are major factors for the rapid expansion of the antimicrobial susceptibility testing market.

In addition, the increasing incidence of hospital-acquired infections (HAIs), the expansion of the patient population (especially in emerging nations), and the government's greater awareness of the need to battle antimicrobial resistance are anticipated to propel the market even further. Moreover, testing evaluates therapeutic services given by clinics, hospitals, and national infectious disease control and preventive programs. As a result of mutations in microbial genes, scientists are now compelled to undertake continuous surveillance of resistance patterns.

According to the Antibiotic Resistant Risks in the United States report, funding from the CDC's AR Solutions Initiative will support all 50 state health departments, many local health departments, Guam,Puerto Rico, and the U.S. Virgin Islands in 2020. From 2016 to 2022, the CDC invested in over 500 novel antimicrobial resistance programs in over 50 countries to prevent the spread of resistance both locally and globally. The well-established awareness campaigns for precision medicine and the use of antimicrobial testing, advantageous government initiatives, and a rising number of collaborative researchesare some of the anticipated market growth drivers.

The US market dominated the North America Antimicrobial Susceptibility Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,293 million by 2028. The Canada market is poised to grow at a CAGR of 7.8% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 6.9% during (2022-2028).

Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Epidemiology & Others. Based on Method, the market is segmented into Automated Susceptibility Testing Instruments, Disk Diffusion, Etest Method, Agar Diffusion, and Genotyping Method. Based on Type, the market is segmented into Antibacterial, Antifungal, Antiparasitic, and Others. Based on End-user, the market is segmented into Hospitals & Diagnostic centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations. Based on Product, the market is segmented into Automated Laboratory Instruments, Manual Laboratory Instruments, Culture & Growth Media and Consumables. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Accelerate Diagnostics, Inc., HiMedia Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.

Scope of the Study

By Application

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Epidemiology & Others

By Method

  • Automated Susceptibility Testing Instruments
  • Disk Diffusion
  • Etest Method
  • Agar Diffusion
  • Genotyping Method

By Type

  • Antibacterial
  • Antifungal
  • Antiparasitic
  • Others

By End-user

  • Hospitals & Diagnostic centers
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Clinical Research Organizations

By Product

  • Automated Laboratory Instruments
  • Manual Laboratory Instruments
  • Culture & Growth Media
  • Consumables

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • BioMérieux S.A.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Bruker Corporation
  • Accelerate Diagnostics, Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • F. Hoffmann-La Roche Ltd.

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Antimicrobial Susceptibility Testing Market, by Application
1.4.2 North America Antimicrobial Susceptibility Testing Market, by Method
1.4.3 North America Antimicrobial Susceptibility Testing Market, by Type
1.4.4 North America Antimicrobial Susceptibility Testing Market, by End-user
1.4.5 North America Antimicrobial Susceptibility Testing Market, by Product
1.4.6 North America Antimicrobial Susceptibility Testing Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition &Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Antimicrobial Susceptibility Testing Market
Chapter 4. North America Antimicrobial Susceptibility Testing Market by Application
4.1 North America Clinical Diagnostics Market by Country
4.2 North America Drug Discovery & Development Market by Country
4.3 North America Epidemiology & Others Market by Country
Chapter 5. North America Antimicrobial Susceptibility Testing Market by Method
5.1 North America Automated Susceptibility Testing Instruments Market by Country
5.2 North America Disk Diffusion Market by Country
5.3 North America Etest Method Market by Country
5.4 North America Agar Diffusion Market by Country
5.5 North America Genotyping Method Market by Country
Chapter 6. North America Antimicrobial Susceptibility Testing Market by Type
6.1 North America Antibacterial Market by Country
6.2 North America Antifungal Market by Country
6.3 North America Antiparasitic Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Antimicrobial Susceptibility Testing Market by End-user
7.1 North America Hospitals & Diagnostic centers Market by Country
7.2 North America Pharmaceutical & Biotechnology Companies Market by Country
7.3 North America Research & Academic Institutes Market by Country
7.4 North America Clinical Research Organizations Market by Country
Chapter 8. North America Antimicrobial Susceptibility Testing Market by Product
8.1 North America Automated Laboratory Instruments Market by Country
8.2 North America Manual Laboratory Instruments Market by Country
8.3 North America Culture & Growth Media Market by Country
8.4 North America Consumables Market by Country
Chapter 9. North America Antimicrobial Susceptibility Testing Market by Country
9.1 US Antimicrobial Susceptibility Testing Market
9.1.1 US Antimicrobial Susceptibility Testing Market by Application
9.1.2 US Antimicrobial Susceptibility Testing Market by Method
9.1.3 US Antimicrobial Susceptibility Testing Market by Type
9.1.4 US Antimicrobial Susceptibility Testing Market by End-user
9.1.5 US Antimicrobial Susceptibility Testing Market by Product
9.2 Canada Antimicrobial Susceptibility Testing Market
9.2.1 Canada Antimicrobial Susceptibility Testing Market by Application
9.2.2 Canada Antimicrobial Susceptibility Testing Market by Method
9.2.3 Canada Antimicrobial Susceptibility Testing Market by Type
9.2.4 Canada Antimicrobial Susceptibility Testing Market by End-user
9.2.5 Canada Antimicrobial Susceptibility Testing Market by Product
9.3 Mexico Antimicrobial Susceptibility Testing Market
9.3.1 Mexico Antimicrobial Susceptibility Testing Market by Application
9.3.2 Mexico Antimicrobial Susceptibility Testing Market by Method
9.3.3 Mexico Antimicrobial Susceptibility Testing Market by Type
9.3.4 Mexico Antimicrobial Susceptibility Testing Market by End-user
9.3.5 Mexico Antimicrobial Susceptibility Testing Market by Product
9.4 Rest of North America Antimicrobial Susceptibility Testing Market
9.4.1 Rest of North America Antimicrobial Susceptibility Testing Market by Application
9.4.2 Rest of North America Antimicrobial Susceptibility Testing Market by Method
9.4.3 Rest of North America Antimicrobial Susceptibility Testing Market by Type
9.4.4 Rest of North America Antimicrobial Susceptibility Testing Market by End-user
9.4.5 Rest of North America Antimicrobial Susceptibility Testing Market by Product
Chapter 10. Company Profiles
10.1 Bruker Corporation
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Product Launches and Product Expansions
10.1.5.2 Acquisition and Mergers
10.2 BioMérieux S.A.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent Strategies and Developments
10.2.5.1 Acquisition and Mergers
10.2.5.2 Approvals and Trials
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent Strategies and Developments
10.3.5.1 Partnerships, Collaborations, and Agreements
10.4 Accelerate Diagnostics, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent Strategies and Developments
10.4.5.1 Product Launches and Product Expansions
10.4.5.2 Approvals and Trials
10.5 Thermo Fisher Scientific, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions
10.6 Danaher Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.7 Bio-Rad laboratories, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 Recent Strategies and Developments
10.7.5.1 Acquisition and Mergers
10.8 Merck KGaA
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 F. Hoffmann-La Roche Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.10. HiMedia Laboratories Pvt. Ltd.
10.10.1 Company Overview

Companies Mentioned

  • BioMérieux S.A.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Bruker Corporation
  • Accelerate Diagnostics, Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • F. Hoffmann-La Roche Ltd.

Methodology

Loading
LOADING...